Digital health fundraises stall for reasons that have nothing to do with the underlying business: the story fails to connect growth metrics with what health-tech investors actually diligence – clinical validation, payer traction, regulatory pathway. Board decks are assembled the week before the meeting rather than maintained as living documents, and when a bridge conversation becomes necessary, the board no longer has the context to act quickly. We build the investor and stakeholder communications infrastructure that keeps your board, cap table, and key partners aligned on where the business truly stands.
The Challenge
Growth metrics are shared without the health-tech context investors need to find them credible
A digital health founder pitching MAU growth or revenue trajectory the same way a generic SaaS founder would misses what a health-tech investor is actually trying to underwrite – clinical outcomes data, payer or provider traction, and regulatory risk. Investors in this category read a metrics-only deck as a signal the founder doesn't understand their own risk profile, which is worse than a mediocre number presented with the right context.
Board reporting is created reactively the week before every meeting, rather than maintained on an ongoing basis
When board materials get assembled from scratch before every meeting, the board only ever sees a curated snapshot instead of a continuous read on the business, which means they can't spot a problem early enough to help, and they can't move fast when a bridge or a difficult decision needs their support. A board that's used to inconsistent, last-minute reporting trusts the numbers less by default, regardless of whether the numbers are actually good.
Digital health companies report to more stakeholder audiences than the average startup, yet most use the same narrative for everyone
A digital health company reports to investors, but also to health system partners, payer relationships, and sometimes a clinical advisory board, and each of those audiences needs a different version of the same story – a payer wants to hear about outcomes and cost, an investor wants to hear about unit economics and market size, a clinical partner wants to hear about safety and efficacy. Running one generic update across every audience means it lands well with none of them.
Difficult conversations – a bridge round, a missed milestone, a pivot – are managed ad hoc, precisely when trust matters most
Most companies have a communication plan for good news and no plan at all for the update that says the milestone slipped or the round needs a bridge, which means the hardest conversation of the company's life gets improvised under pressure. Investors and partners forgive a missed number far more often than they forgive being surprised by one; the surprise, not the miss, is what erodes trust.
How We Support You
We begin by auditing your existing investor and stakeholder materials – board decks, investor updates, and any payer or partner-facing reporting – against what each audience is genuinely trying to learn.
Next, we develop the narrative architecture: the business's core story connected to the specific milestones health-tech investors care about – clinical validation stage, payer or provider traction, regulatory status – with audience-specific versions for your board, investors, and key partners.
We then create the reporting infrastructure – a board reporting template and cadence, an investor update format, and, where relevant, a partner or payer-facing reporting rhythm – so the narrative is maintained continuously rather than reconstructed before each meeting.
We also prepare the plan for the update no one wants to write – a missed milestone, a bridge round, a pivot – before it becomes necessary, ensuring the company isn't improvising its most important communication of the year under pressure.
The materials themselves – decks, one-pagers, update templates – are developed through our creative practice, making the narrative feel credible and specific rather than templated, because health-tech investors have seen enough generic pitch decks to recognize one instantly.
To measure results, we track fundraise velocity – the time from first meeting to term sheet – along with board and stakeholder engagement signals, such as how quickly the board answers a request or how frequently a partner mentions your update materials unprompted. Both are leading indicators of trust that no single fundraise outcome can capture.
Unlike a pitch deck consultant or PR firm, we create continuous infrastructure – narrative, cadence, and a plan for difficult moments – instead of a one-time deliverable for your next fundraise.
What we deliver
- Narrative architecture tied to health-tech-specific milestones – clinical validation, payer traction, regulatory status – not generic growth metrics alone
- Board reporting template and cadence, maintained continuously rather than rebuilt before every meeting
- Audience-specific update formats for investors, board, and key partners, built from one core narrative
- A pre-built plan for difficult updates – missed milestones, bridge conversations, pivots – so the hardest communication isn't improvised
- Fundraise velocity and stakeholder trust tracking, tied to time-to-term-sheet and engagement signals
Investors don't lose confidence when a number comes in low. They lose confidence when it takes them by surprise. The discipline of investor communications ultimately comes down to eliminating the surprise, not improving the number.
Our Methodology
We develop investor and stakeholder communications through the same 90-day sprint. The first 30 days focus on narrative audit and architecture – examining your current materials, identifying the health-tech-specific milestones missing from your story, and creating the core narrative that will inform every update that follows. Days 30 through 60 establish the reporting infrastructure: a board deck template and cadence, an investor update format, audience-specific versions for key partner and payer relationships, and a pre-built plan for a difficult update.
Days 60 through 90 bring the system into operation – completing the first round of board reporting and investor updates on the new cadence, then refining the format according to how your board and investors actually respond. Since board meetings and investor updates follow a recurring calendar, this work gains value across multiple cycles rather than appearing in one deliverable.
This is different from working with a fundraise-specific deck consultant because we create the infrastructure that operates between fundraises, not only for the next raise. A consultant optimizes a single pitch; we establish the reporting discipline and narrative consistency that make each future raise, board meeting, and partner renewal faster because the story and cadence are already in place.
Our Approach
The first 30 days focus on narrative audit and architecture. We examine your current board decks, investor updates, and partner-facing materials, identify the missing health-tech-specific context, and create a core narrative linked to your actual milestones. You receive a clear view of what is working in your stakeholder communications today and what is actively undermining your credibility.
Days 30 through 60 establish the reporting infrastructure – board template and cadence, investor update format, and audience-specific versions when payer or partner relationships require a distinct narrative.
Days 60 through 90 complete the first live cycle – a board meeting and investor update using the new format and cadence – followed by adjustments based on how those audiences actually react.
Most engagements extend beyond the first 90 days as an ongoing communications partnership because board reporting and investor updates follow a recurring calendar, while the narrative must evolve alongside the business. A typical initial build takes three to six months, with ongoing support extending through your next fundraise cycle or significant stakeholder milestone.
- Faster fundraise cycles with fewer surprise objections in diligence
- Board reporting that builds trust between meetings, not just during them
- Stakeholder-specific narratives that land with investors, partners, and payers
- A tested plan for difficult updates instead of an improvised one
If your digital health company needs investor & stakeholder communications leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What does an investor communications engagement cost for a digital health company?
Cost varies based on how many stakeholder audiences require distinct narratives – a company reporting solely to its board and investors is scoped differently from one also managing payer and health-system partner communications – and how much of the reporting infrastructure we continue to operate versus transfer to your team. Most engagements use a project fee for building the narrative and infrastructure, with an optional ongoing retainer for continued reporting support.
How soon will we benefit from stronger investor communications?
The narrative and reporting infrastructure are generally completed during the first 60 days, with the first board meeting or investor update in the new format usually taking place by day 90. The true benefit builds over subsequent cycles – by the second or third board meeting under the new cadence, the trust and context created through consistent reporting begin to show in faster board responses and better-prepared investors entering your next raise conversation.
How do you collaborate with our CEO and current investor relations effort?
We partner directly with your CEO or the person responsible for board and investor relationships because the narrative must authentically reflect the founder's story, not an outsourced voice. We create the infrastructure and can manage elements of the ongoing cadence, but the relationships themselves – the real conversations with your board and investors – remain with your leadership team.
How is Winston Francois different from a pitch deck consultant or IR firm?
A pitch deck consultant creates a single deliverable for one fundraise. We develop the ongoing narrative architecture and reporting cadence that functions between fundraises – board reporting, investor updates, and a pre-built plan for difficult conversations – so each future raise and board meeting draws on a consistent, established story rather than beginning again every time.
How is the ROI of an investor communications engagement measured?
We measure fundraise velocity – time from the first investor meeting to term sheet – alongside stakeholder engagement signals such as board response time and how regularly investors refer to your update materials. Both serve as leading indicators of trust long before the next fundraise event. We also assess whether difficult updates, when they occur, are received as expected news rather than a surprise, since that response is the clearest indication that the narrative work is holding.
What type of digital health company should invest in this service?
This service suits digital health companies from 5M to 100M ARR, ranging from Series A through growth stage, with an active board and investor base and, frequently, payer or health-system partner relationships requiring their own communication line. It delivers the most value to companies approaching a fundraise, bridge conversation, or stage where board and investor trust materially influences execution speed.
